SFM
PTLA
Sphera Funds Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-317,000
| Closed | -$7.57M | – | 108 |
|
2019
Q4 | $7.57M | Buy |
317,000
+57,000
| +22% | +$1.36M | 0.62% | 29 |
|
2019
Q3 | $6.97M | Buy |
+260,000
| New | +$6.97M | 1.08% | 24 |
|
2019
Q1 | – | Sell |
-147,000
| Closed | -$2.87M | – | 127 |
|
2018
Q4 | $2.87M | Hold |
147,000
| – | – | 0.32% | 64 |
|
2018
Q3 | $3.92M | Buy |
147,000
+27,000
| +23% | +$719K | 0.45% | 67 |
|
2018
Q2 | $1.39M | Buy |
+120,000
| New | +$1.39M | 0.19% | 85 |
|
2018
Q1 | – | Sell |
-210,000
| Closed | -$10.2M | – | 152 |
|
2017
Q4 | $10.2M | Buy |
210,000
+65,000
| +45% | +$3.16M | 1.2% | 14 |
|
2017
Q3 | $7.83M | Buy |
145,000
+105,000
| +263% | +$5.67M | 1.12% | 17 |
|
2017
Q2 | $2.25M | Buy |
+40,000
| New | +$2.25M | 0.38% | 70 |
|
2017
Q1 | – | Sell |
-100,000
| Closed | -$2.24M | – | 127 |
|
2016
Q4 | $2.24M | Buy |
+100,000
| New | +$2.24M | 0.57% | 47 |
|
2016
Q2 | – | Sell |
-50,000
| Closed | -$1.02M | – | 111 |
|
2016
Q1 | $1.02M | Sell |
50,000
-35,500
| -42% | -$724K | 0.22% | 74 |
|
2015
Q4 | $4.4M | Sell |
85,500
-9,500
| -10% | -$489K | 0.64% | 24 |
|
2015
Q3 | $4.05M | Buy |
95,000
+9,000
| +10% | +$384K | 0.52% | 30 |
|
2015
Q2 | $3.92M | Sell |
86,000
-14,023
| -14% | -$639K | 0.38% | 53 |
|
2015
Q1 | $3.8M | Buy |
100,023
+30,023
| +43% | +$1.14M | 0.4% | 57 |
|
2014
Q4 | $1.98M | Buy |
+70,000
| New | +$1.98M | 0.34% | 87 |
|
2014
Q1 | – | Sell |
-63,471
| Closed | -$1.63M | – | 128 |
|
2013
Q4 | $1.63M | Buy |
+63,471
| New | +$1.63M | 0.46% | 51 |
|